|
|
Article: FDA Approves Nucleus(R) 24 Double Array; Cochlear Implant Designed for Individuals With Ossified Cochlea.
- Article from:
- PR Newswire
- Article date:
- June 17, 2002
|
Copyright informationCOPYRIGHT 2002 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER -- Cochlear Americas announced today that the Food and Drug Administration (FDA) approved the Nucleus(R) 24 Double Array cochlear implant for use in patients with ossification (bone growth) in their cochlea (inner ear). This bone growth may block the space inside the cochlea preventing the use of conventional cochlear implants, which consist of a single array of electrodes.
The Nucleus 24 Double Array, developed in collaboration with Professor Lenarz at the ORL Clinic, Medical University Hannover, allows patients with significantly ossified cochlea to gain the benefits of cochlear implantation by offering two shorter electrode arrays. Unlike a single ...